AAVivo, Inc., a pioneering biotechnology company developing novel, precision targeted biotherapeutics to enable in vivo generation of CAR-T cells, today announced a presentation at the Society for ...

CAZENOVIA — On Tuesday, Nov. 11, at 6:15 p.m., the Cazenovia Garden Club will welcome citizen scientist Jim English to the Cazenovia Public Library Community Room to present on the history of the ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Plant a seed and, if the conditions are right, the seed grows. The process seems simple enough at first glance and is something many of us may feel like we learned in elementary school.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...